CLINICAL_TRIALS
withdrawal
· 2020-12-10
Clinical Trial Update: Nasal Fentanyl for Chronic Cancer Pain [Phase 3]
Summary
Phase 3 trial of nasal fentanyl for chronic cancer pain was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Norwegian University of Science and Technology | Conditions: Cancer, Pain | Phase 3 | Status: WITHDRAWN